Robotic-assisted techniques in percutaneous coronary intervention: existing research and prospective advancements
-
By
-
Benjamin Bay
-
Moritz Seiffert
-
Fabian J. Brunner
-
July 1, 2026
Clinical Report: Robotic-assisted techniques in percutaneous coronary intervention
Overview
Robotic-assisted percutaneous coronary intervention (rPCI) offers an alternative to manual PCI (mPCI) by reducing occupational radiation exposure for operators while maintaining procedural success. Various rPCI platforms have been developed, demonstrating high clinical success rates and reductions in radiation exposure.
Background
Percutaneous coronary intervention (PCI) is a critical procedure for managing coronary artery disease (CAD), particularly in acute and chronic syndromes. Manual PCI is associated with occupational hazards, including radiation exposure and musculoskeletal disorders for operators. Robotic-assisted techniques aim to mitigate these risks while ensuring effective patient outcomes.
Data Highlights
No specific numerical data provided in the source material.
Key Findings
- Robotic-assisted PCI (rPCI) allows for device manipulation from a remote workstation, reducing operator radiation exposure.
- The first-generation CorPath 200 system demonstrated a 97.6% clinical success rate in the PRECISE study.
- Median radiation exposure for primary operators was reduced by 95.2% with the CorPath 200 system.
- Recent trials indicate that rPCI is safe and effective for selected lesions, with non-inferiority to manual PCI.
- Robotic systems may improve ergonomics for operators.
Clinical Implications
The implementation of rPCI could enhance operator safety by minimizing radiation exposure during procedures. As rPCI technology continues to evolve, it may provide a viable option for treating patients with coronary artery disease, particularly in complex cases.
Conclusion
Robotic-assisted techniques in PCI represent a significant advancement in interventional cardiology, potentially improving safety for operators while maintaining high procedural success rates.
Related Resources & Content
- Frontiers in Medicine, 2026 -- Recent advances in percutaneous coronary intervention for modernizing coronary physiology-guided and device-based strategies for coronary revascularization
- Clinical Research in Cardiology, 2022 -- Current Approaches to Rotational Atherectomy for Calcified Coronary Lesions: Insights from Two Randomized Studies
- Surgical Endoscopy, 2024 -- A Systematic Review of Robotic Surgery Techniques Enhanced by Ultrasound Guidance
- European Radiology, 2023 -- Evaluation of a Novel Robotic-Assisted Endovascular System for Aortic Repair: Initial Human Study on Safety and Feasibility
- ACC, AHA Issue New Acute Coronary Syndromes Guideline - American College of Cardiology, 2025
- Safety and Feasibility of Robotic Percutaneous Coronary Intervention: PRECISE Study | JACC, 2012
- Safety and efficacy of robotic-assisted versus manual percutaneous coronary intervention: a systematic review and updated meta-analysis | Systematic Reviews, 2025
- ACC, AHA Issue New Acute Coronary Syndromes Guideline - American College of Cardiology
- Safety and Feasibility of Robotic Percutaneous Coronary Intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study | JACC
- Safety and efficacy of robotic-assisted versus manual percutaneous coronary intervention: a systematic review and updated meta-analysis | Systematic Reviews | Springer Nature Link
Based on findings from:
Robotic-assisted percutaneous coronary intervention: current evidence and future directions
Benjamin Bay, Moritz Seiffert, Fabian J. Brunner. Frontiers In Cardiovascular Medicine, 2026.
https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1827660/full
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.